Positron Emission Tomography Scanning: Current and Future Applications
Top Cited Papers
- 1 February 2002
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 53 (1), 89-112
- https://doi.org/10.1146/annurev.med.53.082901.104028
Abstract
▪ Abstract Whole-body positron emission tomography (PET) imaging with 18F deoxyglucose (FDG) is a molecular imaging modality that detects metabolic alterations in tumor cells that are common to neoplastic cells. FDG-PET has recently been approved by the Health Care Finance Administration for Medicare reimbursement for diagnosing, staging, and restaging lung cancer, colorectal cancer, lymphoma, melanoma, head and neck cancer, and esophageal cancer. This review discusses the scientific evidence that led to the emergence of PET imaging as an accepted clinical tool in patients with solitary pulmonary nodules, lung cancer, colorectal cancer, melanoma, lymphoma, breast cancer, and other cancers. When possible, we compare the performance of PET to that of anatomical imaging. We discuss future clinical applications of this imaging modality.Keywords
This publication has 76 references indexed in Scilit:
- COMPARISON OF HELICAL COMPUTERIZED TOMOGRAPHY, POSITRON EMISSION TOMOGRAPHY AND MONOCLONAL ANTIBODY SCANS FOR EVALUATION OF LYMPH NODE METASTASES IN PATIENTS WITH PROSTATE SPECIFIC ANTIGEN RELAPSE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCERJournal of Urology, 1999
- Staging of the Axilla in Breast CancerAnnals of Surgery, 1998
- Monitoring of Response to Radiotherapy with Fluorine-18 Deoxyglucose PET of Head and Neck Squamous Cell CarcinomasActa Oto-Laryngologica, 1998
- Metabolische Charakterisierung von Ovarialtumoren mit der Positronen-Emissions-Tomographie und F-18-FluordeoxyglukoseRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1997
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology, 1996
- Cost-effectiveness of PET imaging in clinical oncologyNuclear Medicine and Biology, 1996
- Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imagingEuropean Journal of Surgical Oncology, 1995
- Positron emission tomography for preoperative staging of colorectal carcinomaDiseases of the Colon & Rectum, 1994
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993